Neurology Today in 5

In this week's podcast, Neurology Today's editor-in-chief discusses a study on the safety of omnabotuliumtoxinA on pregnant women with migraine, the impact of the Adderall shortage on patients with ADHD and narcolepsy, and the state of AI for epilepsy. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com f...

In this week's podcast, Neurology Today 's editor-in-chief discusses a new study reporting a gene assay detected Parkinson's before symptoms onset, life stressors greatly impact women with epilepsy during pregnancy; the role of inflammation in new-onset refractory status epilepticus.   This podcast is sponsored by argenx. Visit   www.vyvgarthcp.com   for more information.

In this week's podcast, Neurology Today 's editor-in-chief discusses a new study finding anticoagulants are safe for patients with atrial fibrillation and dementia, women on hormone replacement therapy had higher tau levels, and neurology residents are participants in humanities programs to foster wellness.  

In this week's podcast, Neurology Today 's editor-in-chief discusses a new study finding fertility treatments did not lead to MS relapses for women, a AHA consensus statement that finds stroke systems need improvement, and ravalizumab at less frequent doses was effective for neuromyelitis optica spectrum disorder.

In this week's podcast, Neurology Today's editor-in-chief discusses the newly approved zavegepant for migraine, the potential/caveats of ultrasound ablation for Parkinson's disease, the transational potential of a new therapeutic target for Duchenne muscular atrophy.

In this week's podcast, Neurology Today 's editor-in-chief discusses the increased use of antipsychotics during the pandemic and an associated greater risk for dementia, determining the best biomarkers when considering lecanemab for Alzheimer's, and a novel approach for managing uncomfortable neuropathic symptoms.

In this week's podcast, Neurology Today 's editor-in-chief discusses long-term adverse outcomes from pregnancy-associated stroke, a robotic device to assist shoulder movement in ALS, and the promise of neurostimulation for refractory seizures in the ICU.  

In this week's podcast, Neurology Today 's editor-in-chief discusses the associated risk between acute infections and dementia; alternative therapies to CPAP for sleep apnea; and Dr. Ralph Sacco's impact on the field.  

In this week's podcast, Neurology Today's editor-in-chief discusses the report on outcomes of IV thrombolysis for large vessel occlusions; the discovery of a new brain layer in the subarachnoid space; and the impact of mindfulness and exercise on cognition.

In this week's podcast, Neurology Today 's editor-in-chief discusses the report on misdiagnosis of autoimmune encephalitis, inflationary times for neurologists in private practice, and the editorial board picks for best advances in 2022.

In this week's podcast, Neurology Today 's editor-in-chief discusses a comparison of spinal cord stimulation with medical management for chronic pain, earlier brain aging in Black people, and the pros/cons of working for teleneurology companies.

In this week's podcast, Neurology Today 's editor-in-chief discusses why MS specialists advocate for rituximab for MS, how food security may relate to cognition, and a novel in utero therapy for Pompe diseasea.

In this week's podcast, Neurology Today 's editor-in-chief discusses modifiable risk factors for monogenic stroke, what health care systems need to do to prepare for new Alzheimer's therapies, and criteria program directors apply in selecting neurology residents.

In this week's podcast, Neurology Today 's editor-in-chief discusses data suggesting revascular therapies are safe for patients with stroke and COVID, dementia is associated with increased suicide risk, and the potential of hyperbaric oxygen therapy for children with concussion.

In this week's podcast, Neurology Today's editor-in-chief discusses data suggesting allergic disease is associated with an increased risk of dementia, an increased risk of cancer in children born to women with epilepsy who took high-dose folic acid in pregnancy, and the impact of climate change on people with neurologic disorders.

In this week's podcast, Neurology Today 's editor-in-chief discusses data suggesting vamorolone as an alternative to corticosteroids for Duchenne muscular dystrophy, how an aquaporin protein promotes amyloid clearance, and neurologic events associated with monkeypox virus.

In this week's podcast, Neurology Today 's editor-in-chief discusses new findings on chronic kidney disease and risk for intracerebral hemorrhage, the potential of  gonadotropic replacement for improving cognition in Down syndrome, and distinguishing polio from acute flaccid myelitis and other viruses.

In this week's podcast, Neurology Today 's editor-in-chief discusses new findings on decompression for Chiari malformation, the association of atrial cardiopathy with dementia, and a neurology resident's 3D printing of brain model.

In this week's podcast, Neurology Today 's editor-in-chief discusses the increased associated risk between processed foods and dementia risk, antihistamines vs. benzodiazepines for vertigo, and impostor syndrome in neurology. 

In this week's podcast, Neurology Today 's editor-in-chief discusses spinal cord stimulation for painful diabetic neuropathy, the Roe v. Wade reversal and neurology, and initiatives to diversify the neurology pipeline.

In this week's podcast, Neurology Today 's editor-in-chief discusses new thinking about functional neurologic disorders, the benefits of screening newborns for spinal muscular atrophy, and career advice on when to leave a job in neurology.  

In this week's podcast, Neurology Today 's editor-in-chief discusses new thinking about functional neurologic disorders, the benefits of screening newborns for spinal muscular atrophy, and career advice on when to leave a job in neurology.  

In this week's podcast, Neurology Today 's editor-in-chief discusses RAAS inhibitors for brain aneurysm rupture, the impact of COVID-19 on babies exposed in utero, and how socioeconomic status, independent of genetics, affects brain development.  

In this week's podcast, Neurology Today 's editor-in-chief discusses what's known about monkeypox, soticelstat as a potential new epilepsy therapy, and the potential of gabapentin for stroke recovery.  

In this week's podcast, Neurology Today 's editor-in-chief discusses the approval of fenfluramine for Lennox-Gastaut syndrome, how social isolation affects dementia risk, and the competitiveness of neurology in this year's residency match.